ECSP993105A - THE USE OF ARYL- CYCLLOHEXYLAMINE DERIVATIVES AGAINST DISORDERS OF THE CENTRAL NERVOUS SYSTEM - Google Patents

THE USE OF ARYL- CYCLLOHEXYLAMINE DERIVATIVES AGAINST DISORDERS OF THE CENTRAL NERVOUS SYSTEM

Info

Publication number
ECSP993105A
ECSP993105A ECSP993105A ECSP993105A EC SP993105 A ECSP993105 A EC SP993105A EC SP993105 A ECSP993105 A EC SP993105A EC SP993105 A ECSP993105 A EC SP993105A
Authority
EC
Ecuador
Prior art keywords
alkyl
cycllohexylamine
aryl
nervous system
central nervous
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Bernd Buettelmann
Emmanuel Pinard
Alexander Alanine
Neidhart Marie Paule Heitz
Rene Wyler
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP993105 priority Critical patent/ECSP993105A/en
Publication of ECSP993105A publication Critical patent/ECSP993105A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere al uso de compuestos de la fórmula general (gráfico), en donde Ar1 representa fenilo, naftilo o tetarhidronaftilo, opcionalmente sustituidos por hidroxi, alcoxi-inferior, nitro, amino o matanosulfonamida; Ar2 representa fenilo, naftilo o tetrahidronaftilo, opcionalmente sustituidos por alquil-inferior o halógeno; X representa C, CH, C(OH) o N; Y representa -CH2-, CH u O Z -CH2-, -CH(CH3)- o -C(CH3)2-; R1 representa hidrógeno, alquil-inferior o acetilo; A representa C=0 o -(CHR2)n, en donde R2 representa hidrógeno, alquil-inferior o alquil-inferior-hidroxi; B representa -(CH2)n-, o, -CH(OH) (CH2)n, CH(CH2OH) (CH2)n-, -(CH2)n CH(OH)- o -CH(CH2OH)-; puede representar un enlace y n representa 0-4 y las sales de adición de ácido aceptables farmacéuticamente para la elaboración de medicamentos que representen indicaciones terapéuticas para bloqueadores específicos de subtipos de receptores NMDA.The present invention relates to the use of compounds of the general formula (graph), wherein Ar1 represents phenyl, naphthyl, or tetarhydronaphthyl, optionally substituted by hydroxy, lower alkoxy, nitro, amino, or matanosulfonamide; Ar2 represents phenyl, naphthyl, or tetrahydronaphthyl, optionally substituted by lower-alkyl or halogen; X represents C, CH, C (OH) or N; Y represents -CH2-, CH or O Z -CH2-, -CH (CH3) - or -C (CH3) 2-; R1 represents hydrogen, lower-alkyl or acetyl; A represents C = 0 or - (CHR2) n, where R2 represents hydrogen, lower-alkyl or lower-alkyl-hydroxy; B represents - (CH2) n-, or, -CH (OH) (CH2) n, CH (CH2OH) (CH2) n-, - (CH2) n CH (OH) - or -CH (CH2OH) -; may represent a bond and n represents 0-4 and pharmaceutically acceptable acid addition salts for the manufacture of medicinal products that represent therapeutic indications for specific blockers of NMDA receptor subtypes.

ECSP993105 1999-08-18 1999-08-18 THE USE OF ARYL- CYCLLOHEXYLAMINE DERIVATIVES AGAINST DISORDERS OF THE CENTRAL NERVOUS SYSTEM ECSP993105A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP993105 ECSP993105A (en) 1999-08-18 1999-08-18 THE USE OF ARYL- CYCLLOHEXYLAMINE DERIVATIVES AGAINST DISORDERS OF THE CENTRAL NERVOUS SYSTEM

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP993105 ECSP993105A (en) 1999-08-18 1999-08-18 THE USE OF ARYL- CYCLLOHEXYLAMINE DERIVATIVES AGAINST DISORDERS OF THE CENTRAL NERVOUS SYSTEM

Publications (1)

Publication Number Publication Date
ECSP993105A true ECSP993105A (en) 2000-03-22

Family

ID=42044092

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP993105 ECSP993105A (en) 1999-08-18 1999-08-18 THE USE OF ARYL- CYCLLOHEXYLAMINE DERIVATIVES AGAINST DISORDERS OF THE CENTRAL NERVOUS SYSTEM

Country Status (1)

Country Link
EC (1) ECSP993105A (en)

Similar Documents

Publication Publication Date Title
AR039219A1 (en) IMIDAZO-REPLACED COMPOUNDS
AR027437A1 (en) PURINA DERIVATIVES
UY27092A1 (en) DERIVATIVES OF THE NEW QUINUCLIDINE CARBAMATE AND THE MEDICINAL COMPOSITIONS CONTAINING THEM
ES2164920T3 (en) NEW HETEROCICLIC DERIVATIVES AND MEDICINAL USE OF THE SAME.
TR200101969T2 (en) Substituted benzopyran analogs for the treatment of inflammation.
AR020727A1 (en) USE OF 3-AMINO-4-ARIL-MALEIMIDAS DERIVATIVE COMPOUNDS FOR THE PREPARATION OF MEDICINES FOR CONDITIONS ASSOCIATED WITH A NEED FOR INHIBITION OF LAGSK-3, SUCH COMPOUNDS, PROCEDURE FOR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM
CR7743A (en) NEW OXAZOL AND TIAZOL COMPOUNDS AS INHIBITOR OF THE TRANSFORMING GROWTH FACTOR (TGF)
AR025444A1 (en) DERIVATIVES OF SULFONIL-CARBOXAMIDE, PROCEDURES FOR ITS PREPARATION AND ITS USE AS MEDICATIONS
AR035153A1 (en) CARBOXAMID DERIVATIVES AND DIHYDROBENZODIOXINE KETONES
ECSP088405A (en) NEW DERIVATIVES OF PIRIMIDINE AND ITS USE IN THERAPY, AS WELL AS THE USE OF PIRIMIDINE DERIVATIVES IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE PREVENTION AND / OR TREATMENT OF ALZHEIMER'S DISEASE
PA8551001A1 (en) NEW COMPOUNDS
AR024060A1 (en) NEW PHARMACEUTICALLY ACTIVE COMPOUNDS
ITTO910939A1 (en) ALPHA-OXYACETAMIDE DERIVATIVE.
ES2136037B1 (en) SULFAMIDE-METALOPROTEASE INHIBITORS
AR016431A1 (en) DERIVATIVES OF PIPERIDINE, A PROCESS FOR THEIR PREPARATION, DRUGS THAT UNDERSTAND THEM AND THE USE OF SUCH DERIVATIVES FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
EA200601194A1 (en) NEW DERIVATIVES OF BENZOFURANE USED FOR THE PREVENTION OR TREATMENT OF DISTURBANCES ASSOCIATED WITH 5-HT-RECEPTOR
AR012504A1 (en) USE OF TETRAHYDROPYRIDINE DERIVATIVES, FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF DISEASES WHICH CAUSE A DEMELINATION.
AR025046A1 (en) IL-5 NON-STEROID INHIBITORS, PROCEDURES AND INTERMEDIARIES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT INCLUDE SUCH INHIBITORS
AR050956A1 (en) BENCIMIDAZOL DERIVATIVES; SYNTHESIS OF THE SAME; PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THE PREPARATION OF MEDICINES FOR THE TREATMENT OF DISEASES MEDIATED BY LEGENDS OF THE CB1 RECEIVER.
Francisco et al. Intramolecular 1, 5-hydrogen atom transfer reaction promoted by phosphoramidyl and carbamoyl radicals: synthesis of 2-amino-C-glycosides
BR0312175A (en) Compound, pharmaceutical composition, use of a compound, method of treatment and method for reducing morbidity and mortality associated with overweight
AR021770A1 (en) THE USE OF ARILCICLOHEXYLAMINE DERIVATIVES AGAINST DISORDERS OF THE CENTRAL NERVOUS SYSTEM
CL2004000779A1 (en) COMPOUNDS DERIVED FROM 3-AZABICICLO [3.2.1] OCTANO, PHARMACEUTICAL COMPOSITION, PREPARATION PROCEDURE, USEFUL TO PREPARE MEDICATIONS TO TREAT IRRITABLE INTESTINE SYNDROME, RELEASE, NAUSEAS, VOMITES, SEXUAL DYSFUNCTION, ALZHE
BRPI0412239A (en) emulsifying systems containing azetidine derivatives
AR035008A1 (en) PIRIMIDIN-2, 4, 6-TRIONAS COMPOUNDS, THEIR USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM